Literature DB >> 14711059

Control of autoimmunity by naturally arising regulatory CD4+ T cells.

Shohei Hori1, Takeshi Takahashi, Shimon Sakaguchi.   

Abstract

Naturally acquired immunological self-tolerance is not entirely accounted for by clonal deletion, anergy, and ignorance. It is now well established that the T cell-repertoire of healthy individuals harbors self-reactive lymphocytes with a potential to cause autoimmune disease and these lymphocytes are under dominant control by a unique subpopulation of CD4+ T cells now called regulatory T cells. Efforts to delineate these Treg cells naturally present in normal individuals have revealed that they are enriched in the CD25+ CD4+ population. The identification of the CD25 molecule as a useful marker for naturally arising CD4+ regulatory T cells has made it possible to investigate many key aspects of their immunobiology, including their antigen specificities and the cellular/molecular pathways involved in their development and their mechanisms of action. Furthermore, reduction or dysfunction of the CD25+ CD4+ regulatory T cell population can be responsible for certain autoimmune diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14711059     DOI: 10.1016/s0065-2776(03)81008-8

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  82 in total

1.  Stability of the regulatory T cell lineage in vivo.

Authors:  Yuri P Rubtsov; Rachel E Niec; Steven Josefowicz; Li Li; Jaime Darce; Diane Mathis; Christophe Benoist; Alexander Y Rudensky
Journal:  Science       Date:  2010-09-24       Impact factor: 47.728

Review 2.  Prognostic significance of autoimmunity during treatment of melanoma with interferon.

Authors:  Michal T Krauze; Ahmad Tarhini; Helen Gogas; John M Kirkwood
Journal:  Semin Immunopathol       Date:  2011-01-31       Impact factor: 9.623

3.  Early preplasma cells define a tolerance checkpoint for autoreactive B cells.

Authors:  Donna A Culton; Brian P O'Conner; Kara L Conway; Ramiro Diz; Jennifer Rutan; Barbara J Vilen; Stephen H Clarke
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 4.  Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

Authors:  Christopher A Klebanoff; Hung T Khong; Paul A Antony; Douglas C Palmer; Nicholas P Restifo
Journal:  Trends Immunol       Date:  2005-02       Impact factor: 16.687

5.  Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.

Authors:  Zhi-Zhang Yang; Anne J Novak; Mary J Stenson; Thomas E Witzig; Stephen M Ansell
Journal:  Blood       Date:  2006-01-10       Impact factor: 22.113

6.  Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study.

Authors:  Elizabeth A Platz; Charles G Drake; Kathryn M Wilson; Siobhan Sutcliffe; Stacey A Kenfield; Lorelei A Mucci; Meir J Stampfer; Walter C Willett; Carlos A Camargo; Edward Giovannucci
Journal:  Int J Cancer       Date:  2015-02-27       Impact factor: 7.396

Review 7.  Retinoic acid in the immune system.

Authors:  Karina Pino-Lagos; Micah J Benson; Randolph J Noelle
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 8.  Function of tumor necrosis factor receptor family members on regulatory T-cells.

Authors:  Robert H Arch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 9.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.